{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T15:08:33Z","timestamp":1771600113755,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004048","name":"Kashan University of Medical Sciences","doi-asserted-by":"publisher","award":["400002"],"award-info":[{"award-number":["400002"]}],"id":[{"id":"10.13039\/501100004048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12601-6","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T06:39:34Z","timestamp":1769668774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of antiphospholipid antibodies in the severity and outcome of COVID-19"],"prefix":"10.1186","volume":"26","author":[{"given":"Batool","family":"Zamani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maedeh","family":"Najafizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atiye","family":"Jokar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Habibollah","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Motedayyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"12601_CR1","doi-asserted-by":"publisher","first-page":"205873842096649","DOI":"10.1177\/2058738420966497","volume":"34","author":"F Fathi","year":"2020","unstructured":"Fathi F, Sami R, Mozafarpoor S, Hafezi H, Motedayyen H, Arefnezhad R, et al. Immune system changes during COVID-19 recovery play key role in determining disease severity. Int J ImmunoPathol Pharmacol. 2020;34:2058738420966497.","journal-title":"Int J ImmunoPathol Pharmacol"},{"key":"12601_CR2","doi-asserted-by":"publisher","first-page":"155439","DOI":"10.1016\/j.cyto.2021.155439","volume":"140","author":"R Sami","year":"2021","unstructured":"Sami R, Fathi F, Eskandari N, Ahmadi M, ArefNezhad R, Motedayyen H. Characterizing the immune responses of those who survived or succumbed to COVID-19: can immunological signatures predict outcome? Cytokine. 2021;140:155439.","journal-title":"Cytokine"},{"issue":"3","key":"12601_CR3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/15321819.2022.2164506","volume":"44","author":"B Zamani","year":"2023","unstructured":"Zamani B, Momen-Heravi M, Erami M, Motedayyen H, ArefNezhad R. Impacts of IL-27 and IL-32 in the pathogenesis and outcome of COVID-19 associated mucormycosis. J Immunoass Immunochemistry. 2023;44(3):242\u201355.","journal-title":"J Immunoass Immunochemistry"},{"key":"12601_CR4","doi-asserted-by":"crossref","unstructured":"Zamani B, Najafi A, Ghavamnezhad K, Sheikhi Nooshabadi M, Akbari H. Motedayyen H. Investigation of adalimumab (CinnoRA) effects in controlling the severe form of COVID-19: a randomized controlled trial. Asthma Allergy Immunol (Astim Allerji Immunoloji). 2025;23(1).","DOI":"10.21911\/aai.2025.654"},{"key":"12601_CR5","doi-asserted-by":"publisher","first-page":"039463202412392","DOI":"10.1177\/03946320241239202","volume":"38","author":"A Moradi Hasan-Abad","year":"2024","unstructured":"Moradi Hasan-Abad A, Arbabi M, Gilasi H, Motedayyen H. Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population. Int J ImmunoPathol Pharmacol. 2024;38:03946320241239202.","journal-title":"Int J ImmunoPathol Pharmacol"},{"key":"12601_CR6","doi-asserted-by":"publisher","first-page":"108427","DOI":"10.1016\/j.clim.2020.108427","volume":"215","author":"K Yuki","year":"2020","unstructured":"Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol. 2020;215:108427.","journal-title":"Clin Immunol"},{"issue":"1","key":"12601_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/ijerph18010194","volume":"18","author":"J-Y Kim","year":"2021","unstructured":"Kim J-Y, Kim H-N. Changes in inflammatory cytokines in saliva after Non-Surgical periodontal therapy: A systematic review and Meta-Analysis. Int J Environ Res Public Health. 2021;18(1):194.","journal-title":"Int J Environ Res Public Health"},{"issue":"11","key":"12601_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00203-025-04513-x","volume":"207","author":"B Zamani","year":"2025","unstructured":"Zamani B, Momen-Heravi M, Shams M-H, Motedayyen H, Arefnezhad R. Impacts of adipokines in the development and consequence of COVID-19-associated mucormycosis. Arch Microbiol. 2025;207(11):303.","journal-title":"Arch Microbiol"},{"key":"12601_CR9","doi-asserted-by":"publisher","first-page":"039463202211458","DOI":"10.1177\/03946320221145827","volume":"36","author":"B Zamani","year":"2022","unstructured":"Zamani B, Najafizadeh M, Motedayyen H, Arefnezhad R. Predicting roles of IL-27 and IL-32 in determining the severity and outcome of COVID-19. Int J ImmunoPathol Pharmacol. 2022;36:03946320221145827.","journal-title":"Int J ImmunoPathol Pharmacol"},{"key":"12601_CR10","unstructured":"Fauci AS. Harrison\u2019s principles of internal medicine. McGraw-Hill Education; 2015."},{"issue":"2","key":"12601_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"12601_CR12","doi-asserted-by":"publisher","first-page":"e858","DOI":"10.1002\/iid3.858","volume":"11","author":"B Zamani","year":"2023","unstructured":"Zamani B, Moradi Hasan-Abad A, Piroozmand A, Dehghani M, Arfaatabar M, Motedayyen H. Immunogenicity and safety of the BBIBP\u2010CorV vaccine in patients with autoimmune inflammatory rheumatic diseases undergoing immunosuppressive therapy in a monocentric cohort. Immun Inflamm Dis. 2023;11(5):e858.","journal-title":"Immun Inflamm Dis"},{"issue":"2","key":"12601_CR13","first-page":"e200067","volume":"2","author":"Y Xie","year":"2020","unstructured":"Xie Y, Wang X, Yang P, Zhang S. COVID-19 complicated by acute pulmonary embolism. Radiology: Cardiothorac Imaging. 2020;2(2):e200067.","journal-title":"Radiology: Cardiothorac Imaging"},{"issue":"9","key":"12601_CR14","first-page":"1379","volume":"2","author":"W Ullah","year":"2020","unstructured":"Ullah W, Saeed R, Sarwar U, Patel R, Fischman DL. COVID-19 complicated by acute pulmonary embolism and right-sided heart failure. Case Rep. 2020;2(9):1379\u201382.","journal-title":"Case Rep"},{"issue":"3","key":"12601_CR15","first-page":"247","volume":"14","author":"M Bansal","year":"2020","unstructured":"Bansal M. Cardiovascular disease and COVID-19. Diabetes & metabolic syndrome. Clin Res Reviews. 2020;14(3):247\u201350.","journal-title":"Clin Res Reviews"},{"issue":"4","key":"12601_CR16","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844\u20137.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"12601_CR17","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","volume":"46","author":"J Helms","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089\u201398.","journal-title":"Intensive Care Med"},{"key":"12601_CR18","doi-asserted-by":"crossref","unstructured":"Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC-C, et al. Infectious Diseases Society of America Guidelines on the treatment and management of patients with coronavirus disease 2019 (COVID-19). Clin Inf Dis. 2020.","DOI":"10.1093\/cid\/ciaa478"},{"issue":"25","key":"12601_CR19","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","volume":"383","author":"DA Berlin","year":"2020","unstructured":"Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. N Engl J Med. 2020;383(25):2451\u201360.","journal-title":"N Engl J Med"},{"issue":"2","key":"12601_CR20","first-page":"e200152","volume":"2","author":"S Simpson","year":"2020","unstructured":"Simpson S, Kay FU, Abbara S, Bhalla S, Chung JH, Chung M, et al. Radiological society of North America expert consensus document on reporting chest CT findings related to COVID-19: endorsed by the society of thoracic Radiology, the American college of Radiology, and RSNA. Radiology: Cardiothorac Imaging. 2020;2(2):e200152.","journal-title":"Radiology: Cardiothorac Imaging"},{"issue":"5","key":"12601_CR21","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jth.14810","volume":"18","author":"J Thachil","year":"2022","unstructured":"Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2022;18(5):1023.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"12601_CR22","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.21037\/jtd-20-3062","volume":"13","author":"A Garc\u00eda-Ortega","year":"2021","unstructured":"Garc\u00eda-Ortega A, de la Rosa D, Oscullo G, Castillo-Villegas D, L\u00f3pez-Reyes R, Mart\u00ednez-Garc\u00eda M\u00c1. Coagulation disorders and thromboembolic disease in COVID-19: review of current evidence in search of a better approach. J Thorac Disease. 2021;13(2):1239.","journal-title":"J Thorac Disease"},{"issue":"9","key":"12601_CR23","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.3390\/ijms23094946","volume":"23","author":"M Serrano","year":"2022","unstructured":"Serrano M, Espinosa G, Serrano A, Cervera R. Antigens and antibodies of the antiphospholipid syndrome as new allies in the pathogenesis of COVID-19 coagulopathy. Int J Mol Sci. 2022;23(9):4946.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12601_CR24","doi-asserted-by":"publisher","first-page":"rkaa081","DOI":"10.1093\/rap\/rkaa081","volume":"5","author":"ML Tung","year":"2021","unstructured":"Tung ML, Tan B, Cherian R, Chandra B. Anti-phospholipid syndrome and COVID-19 thrombosis: connecting the Dots. Rheumatol Adv Pract. 2021;5(1):rkaa081.","journal-title":"Rheumatol Adv Pract"},{"issue":"8","key":"12601_CR25","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/biomedicines9080899","volume":"9","author":"FJ Gil-Etayo","year":"2021","unstructured":"Gil-Etayo FJ, Garcinu\u00f1o S, Lalueza A, D\u00edaz-Sim\u00f3n R, Garc\u00eda-Reyne A, Pleguezuelo DE, et al. Anti-phospholipid antibodies and COVID-19 thrombosis: a co-star, not a supporting actor. Biomedicines. 2021;9(8):899.","journal-title":"Biomedicines"},{"issue":"17","key":"12601_CR26","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38.","journal-title":"N Engl J Med"},{"issue":"8","key":"12601_CR27","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1111\/jth.14867","volume":"18","author":"I Harzallah","year":"2020","unstructured":"Harzallah I, Debliquis A, Dr\u00e9nou B. Lupus anticoagulant is frequent in patients with Covid-19. J Thromb Haemost. 2020;18(8):2064\u20135.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"12601_CR28","doi-asserted-by":"publisher","first-page":"e001580","DOI":"10.1136\/rmdopen-2021-001580","volume":"7","author":"M Taha","year":"2021","unstructured":"Taha M, Samavati L. Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review. RMD Open. 2021;7(2):e001580.","journal-title":"RMD Open"},{"issue":"1","key":"12601_CR29","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.thromres.2009.09.001","volume":"125","author":"SM Schouwers","year":"2010","unstructured":"Schouwers SM, Delanghe JR, Devreese KM. Lupus anticoagulant (LAC) testing in patients with inflammatory status: does C-reactive protein interfere with LAC test results? Thromb Res. 2010;125(1):102\u20134.","journal-title":"Thromb Res"},{"issue":"5","key":"12601_CR30","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1515\/cclm-2014-0906","volume":"53","author":"KM Devreese","year":"2015","unstructured":"Devreese KM, Verfaillie CJ, De Bisschop F, Delanghe JR. Interference of C-reactive protein with clotting times. Clin Chem Lab Med (CCLM). 2015;53(5):e141\u20135.","journal-title":"Clin Chem Lab Med (CCLM)"},{"issue":"8","key":"12601_CR31","doi-asserted-by":"publisher","first-page":"e2017539","DOI":"10.1001\/jamanetworkopen.2020.17539","volume":"3","author":"MR Gil","year":"2020","unstructured":"Gil MR, Barouqa M, Szymanski J, Gonzalez-Lugo JD, Rahman S, Billett HH. Assessment of lupus anticoagulant positivity in patients with coronavirus disease 2019 (COVID-19). JAMA Netw Open. 2020;3(8):e2017539\u2013e.","journal-title":"JAMA Netw Open"},{"key":"12601_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-021-01029-3","volume":"23","author":"T Foret","year":"2021","unstructured":"Foret T, Dufrost V, Salomon Du Mont L, Costa P, Lefevre B, Lacolley P, et al. Systematic review of antiphospholipid antibodies in COVID-19 patients: culprits or bystanders? Curr Rheumatol Rep. 2021;23:1\u201311.","journal-title":"Curr Rheumatol Rep"},{"key":"12601_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.thromres.2020.07.016","volume":"195","author":"V Siguret","year":"2020","unstructured":"Siguret V, Voicu S, Neuwirth M, Delrue M, Gayat E, St\u00e9panian A, et al. Are antiphospholipid antibodies associated with thrombotic complications in critically ill COVID-19 patients? Thromb Res. 2020;195:74\u20136.","journal-title":"Thromb Res"},{"issue":"2","key":"12601_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.amjms.2022.10.012","volume":"365","author":"G Garcia-Arellano","year":"2023","unstructured":"Garcia-Arellano G, Camacho-Ortiz A, Moreno-Arquieta IA, Cardenas-de la Garza JA, Rubio-Torres DC, Garza-Gonzalez E, et al. Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19. Am J Med Sci. 2023;365(2):215\u20137.","journal-title":"Am J Med Sci"},{"issue":"1","key":"12601_CR35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11239-020-02335-w","volume":"52","author":"C Gazzaruso","year":"2021","unstructured":"Gazzaruso C, Mariani G, Ravetto C, Malinverni L, Tondelli E, Cerrone M, et al. Lupus anticoagulant and mortality in patients hospitalized for COVID-19. J Thromb Thrombolysis. 2021;52(1):85\u201391.","journal-title":"J Thromb Thrombolysis"},{"key":"12601_CR36","first-page":"1953","volume-title":"Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity","author":"D Bertin","year":"2020","unstructured":"Bertin D, Brodovitch A, Beziane A, Hug S, Bouamri A, Mege JL, et al. Anticardiolipin IgG autoantibody level is an independent risk factor for COVID-19 severity. Volume 72. Hoboken, NJ: Arthritis & Rheumatology; 2020. p. 1953. 11."},{"issue":"6","key":"12601_CR37","doi-asserted-by":"publisher","first-page":"102822","DOI":"10.1016\/j.autrev.2021.102822","volume":"20","author":"O Vollmer","year":"2021","unstructured":"Vollmer O, Tacquard C, Dieudonn\u00e9 Y, Nespola B, Sattler L, Grunebaum L, et al. Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent. Autoimmun Rev. 2021;20(6):102822.","journal-title":"Autoimmun Rev"},{"issue":"8","key":"12601_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4103\/1995-7645.321611","volume":"14","author":"CS Wahono","year":"2021","unstructured":"Wahono CS, Susianti H, Dantara TWI, Rahman PA, Pratama MZ, Wulanda IA, et al. Prevalence and clinical significance of antiphospholipid antibodies among hospitalized COVID-19 patients. Asian Pac J Trop Med. 2021;14(8):350.","journal-title":"Asian Pac J Trop Med"},{"key":"12601_CR39","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3389\/fneur.2020.00806","volume":"11","author":"S Fan","year":"2020","unstructured":"Fan S, Xiao M, Han F, Xia P, Bai X, Chen H, et al. Neurological manifestations in critically ill patients with COVID-19: a retrospective study. Front Neurol. 2020;11:806.","journal-title":"Front Neurol"},{"issue":"9","key":"12601_CR40","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1161\/STROKEAHA.120.030995","volume":"51","author":"A Rothstein","year":"2020","unstructured":"Rothstein A, Oldridge O, Schwennesen H, Do D, Cucchiara BL. Acute cerebrovascular events in hospitalized COVID-19 patients. Stroke. 2020;51(9):e219\u201322.","journal-title":"Stroke"},{"issue":"3","key":"12601_CR41","first-page":"E319","volume":"97","author":"B Popovic","year":"2021","unstructured":"Popovic B, Varlot J, Metzdorf PA, Jeulin H, Goehringer F, Camenzind E. Changes in characteristics and management among patients with ST-elevation myocardial infarction due to COVID\u201019 infection. Catheter Cardiovasc Interv. 2021;97(3):E319\u201326.","journal-title":"Catheter Cardiovasc Interv"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12601-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T14:19:32Z","timestamp":1771597172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12601-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12601"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12601-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"13 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Kashan University of Medical Sciences (IR.KAUMS.REC.1400.027). Written informed consent was obtained from all participants and legally authorized representatives of dead patients before study initiation. All experiments and protocols were performed in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"433"}}